Samantha de Almeida
Primary Care · Nutley, NJNPI 1770931396
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations.
Across 184 payments — averaging $14.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$583
- Pfizer$220
- Bayer$220
- AstraZeneca$194
- Amarin Pharma, Inc.$193
- Lilly USA, LLC$179
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,690100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 40 | $583 |
| Pfizer | 15 | $220 |
| Bayer | 14 | $220 |
| AstraZeneca | 12 | $194 |
| Amarin Pharma, Inc. | 15 | $193 |
| Lilly USA, LLC | 12 | $179 |
| Boehringer Ingelheim | 11 | $159 |
| Idorsia Pharmaceuticals US Inc | 11 | $132 |
| Almatica Pharma LLC | 8 | $114 |
| GSK | 7 | $101 |
| Exact Sciences | 4 | $75 |
| Amgen | 5 | $69 |
| Lundbeck LLC | 4 | $65 |
| Novartis | 3 | $45 |
| AbbVie | 3 | $43 |
| Azurity Pharmaceuticals, Inc. | 2 | $33 |
| Astellas Pharma US Inc | 2 | $30 |
| Seqirus USA Inc | 2 | $29 |
| Althera Pharmaceuticals LLC | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Amphastar Pharmaceuticals, Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| Urovant Sciences Inc | 1 | $15 |
| Merck | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
How this compares
$2,690 in reported general payments places this provider in the 85th percentile of 330 primary care providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 21 | $34,378 |
| FarxigaDapagliflozin Propanediol | 14 | $12,646 |
| VascepaIcosapent Ethyl | 16 | $8,445 |
| TradjentaLinagliptin | 13 | $8,270 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $8,044 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $4,332 |
| Atorvastatin Calcium | 107 | $1,269 |
| Rosuvastatin Calcium | 36 | $1,029 |
| Levothyroxine Sodium | 87 | $928 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $676 |
| Amlodipine Besylate | 91 | $655 |
| Metoprolol Succinate | 35 | $589 |
| Metformin Hcl | 72 | $548 |
| Azelastine Hcl | 15 | $300 |
| Pantoprazole Sodium | 17 | $285 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $159 | $42,64834 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $194 | $20,69128 claims |
| Almatica Pharma LLCSertraline Hcl | $114 | $7016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 330 primary care providers in New Jersey.
Other primary care in Nutley
- Michael Zito GovertNeptune$61K
- Roseann BenantiEnglewood$24K
- Marcelo MarinEnglewood$17K
- Jennifer EdwardsPrinceton$14K
- Mary Grace TolentinoJersey City$9K
- Kevin Robert ReyladoNorth Arlington$8K
- Carlo SebelloJersey City$8K
- Karam WehbehPaterson$7K
- Shazam BacchusNewark$7K
- Anna NievesBasking Ridge$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.